We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Urology Database to Evaluate Clinical Information and Improve Patient Care.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00376298
Recruitment Status : Completed
First Posted : September 14, 2006
Last Update Posted : December 24, 2015
Information provided by (Responsible Party):

Study Description
Brief Summary:
The purpose of initiating the Urology Database is to evaluate the outcomes of urology procedures and medical management to enhance the care and treatment of urology patients.

Condition or disease
Incontinence Prostate Cancer Interstitial Cystitis Urinary Retention Pelvic Organ Prolapse

Detailed Description:
The current study population will include all patients having had a radical prostatectomy for the treatment of prostate cancer, surgical prolapse repair as well as patients having had InterStim sacral nerve stimulator implantation. The database will house data extracted from the medical records. Patient demographics, and preoperative, intra-operative, postoperative, and follow-up clinical data will be collected.

Study Design

Study Type : Observational
Actual Enrollment : 215 participants
Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Urology Database for Outcomes Research
Study Start Date : February 2004
Primary Completion Date : December 2015
Study Completion Date : December 2015

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts

Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Men and Women with conditions including radical prostatectomy, pelvic organ prolapse and neurostimulator implantation at William Beaumont Hospital

Inclusion Criteria:

All patients undergoing radical prostatectomy, pelvic organ prolapse repair and neurostimulator (Interstim) implantation at William Beaumont Hospital beginning January 1, 1998, as well as other urology patients as research questions are identified. Only patients who have accepted William Beaumont Hospital's Privacy Notices will be included in the database.

Exclusion Criteria:

Patients not acknowledging acceptance of William Beaumont Hospital's Privacy Notices.

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00376298

United States, Michigan
William Beaumont Hospital
Royal Oak, Michigan, United States, 48073
Sponsors and Collaborators
Kenneth Peters, MD
William Beaumont Hospitals
Principal Investigator: Kenneth Peters, MD William Beaumont Hospitals
More Information

Responsible Party: Kenneth Peters, MD, Principal Investigator, William Beaumont Hospitals
ClinicalTrials.gov Identifier: NCT00376298     History of Changes
Other Study ID Numbers: 2004-050
First Posted: September 14, 2006    Key Record Dates
Last Update Posted: December 24, 2015
Last Verified: December 2015

Keywords provided by Kenneth Peters, MD, William Beaumont Hospitals:
prostate cancer
interstitial cystitis

Additional relevant MeSH terms:
Prostatic Neoplasms
Pelvic Organ Prolapse
Cystitis, Interstitial
Urinary Retention
Genital Neoplasms, Male
Urogenital Neoplasms
Neoplasms by Site
Genital Diseases, Male
Prostatic Diseases
Pathological Conditions, Anatomical
Urinary Bladder Diseases
Urologic Diseases
Urination Disorders